DENTSPLY SIRONA (XRAY) Form 3 DENTSPLY SIRONA / ROBERT J. SIZE ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

SIZE ROBERT J.

(Last) (First) (Middle)

221 W PHILADELPHIA STREET, STE 60W

(Street)

YORK PA 17401

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/28/2017

3. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Interim President and COO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	20,012(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(2)	12/08/2019	Common Stock	38,000	33.86	D
Stock Option (Right to Buy)	(2)	02/11/2021	Common Stock	31,900	36.62	D
Stock Option (Right to Buy)	(2)	02/21/2022	Common Stock	25,600	38.74	D
Stock Option (Right to Buy)	(2)	02/25/2023	Common Stock	20,600	40.86	D
Stock Option (Right to Buy)	(2)	02/24/2024	Common Stock	25,300	45.11	D
Stock Option (Right to Buy)	(3)	02/23/2025	Common Stock	12,933	52	D
Stock Option (Right to Buy)	(4)	02/17/2026	Common Stock	15,000	55.91	D
Phantom Stock (Supplemental Executive Retirement Plan) SERP	(5)	(5)	Common Stock	16,457.928	(5)	D
PRSU (Performance Measured Restricted Stock Unit)	(6)	(6)	Common Stock	4,673.916(7)	(6)	D
RSU (Restricted Stock Unit)	(8)	(8)	Common Stock	8,349.605(9)	(8)	D
Stock Option (Right to Buy)	(10)	09/28/2027	Common Stock	52,200	59.23	D

Explanation of Responses:

1. Includes 10,105 Restricted Stock Units (RSUs) granted 9/28/2017.

2. This option is fully vested and exercisable.

3. Stock Options vest in annual one-third (1/3) increments over a three-year period ending February 23, 2018.

4. Stock Options vest in annual one-third (1/3) increments over a three-year period ending February 17, 2019.

5. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment.

6. PRSUs vest in full three years from date of grant and convert into common stock on a 1:1 basis for no additional consideration.

7. Includes 4,607 Performance Restricted Stock Units (PRSUs) and 66.916 dividends on PRSUs.

8. RSUs vest in full three years from date of grant and convert into common stock on a 1:1 basis for no additional consideration.

9. Includes 8,261 Restricted Stock Units (RSUs) and 88.605 dividends on RSUs.

10. Stock options vest December 31, 2018 or upon reporting person's termination of employment, whichever occurs first.

	Michael Friedlander, Attorney-In-Fact for Robert J. Size	10/10/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.